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1. Introduction 
Binding sites for human growth hormone have 
recently been identified in various tissues from 
various species [l-6] . In certain cases, such as with 
cultured human lymphocytes [5,6] and rabbit liver 
membranes [l-3] , these sites bind exclusively or 
predominantly growth hormones; in other cases, such 
as with rat liver membranes, they also bind hormones 
possessing lactogenic activity [3,4] . On the basis of 
these findings, the existence of two distinct types of 
hGH binding sites, ‘somatotropic’ and ‘lactogenic’, 
has been postulated. 
Earlier studies [2-41 have shown that, in liver 
membranes of female rats, the hGH binding sites have 
almost exclusively ‘lactogenic’ specificity; it was also 
demonstrated that the hGH binding capacity increases 
in female rats after puberty. With liver membranes of 
male rats, there was much less binding than with those 
of female animals, and the specificity of the binding 
sites was not assessed. 
In the present studies we demonstrate the existence, 
in rat liver membranes, of ‘somatotropic’ sites in 
addition to the ‘lactogenic’ sites. In membranes of 
male rats the somatotropic sites account for virtually 
all the binding sites for hGH, whereas in those of 
female animals, they represent only a small fraction 
of the hGH binding sites. The variation, with sex and 
age, of the somatotropic sites has been investigated 
Abbrevations: hGH, Human growth hormone; bGH, Bovine 
growth hormone; oPRL, Ovine prolactin; SEM, Standard error 
of the mean. 
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using [ ] “‘1 bovine growth hormone as the tracer; 
unlike hGH, bGH does not possess lactogenic activity. 
In membranes of male rats, the number of somato- 
tropic sites is the same before and after puberty, where- 
as in female rats, a 2-fold increase in the bGH binding 
capacity occurs after puberty. 
2. Materials and methods 
Rats, male and female of various ages, were obtained 
from Charles River France. They were given laboratory 
chow ad libitum until sacrifice. 
2. I. Liver membranes preparation 
Liver membranes (‘microsomal fraction’) were 
prepared by differential centrifugation of rat liver 
homogenates in 0.25 M sucrose solution [7]. Protein 
concentration was determined by the method of 
Lowry [8] using bovine serum albumin as a standard. 
2.2. Hormones 
hGH (2 IU/mg) was purified at URIA, Institut 
Pasteur, Paris, France; bGH was a gift from Dr Martin 
Sonenberg, Sloan-Kettering Institute for Cancer 
Research, New York; oPRL (NIH-PS II) was kindly 
donated by the National Institute of Arthritis and 
Metabolic Diseases, National Institute of Health, 
Bethesda, Md., USA. 
2.3. Iodination of hormones 
[rz51]hGH was prepared by a modification of the 
method of Greenwood, Hunter and Glover as described 
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by Lesniak et al. .[9,5] ; its specific activity ranged 
from 50- 120 &i/pg hGH. The same procedure was 
used to prepare [ lz51] bGH. [1251] oPRL was prepared 
using lactoperoxidase (Calbiochem.) as described by 
Thorell and Johansson [lo] and purified by gel filtra- 
tion on a Sephadex G-75 column. 
2.4. Assay procedure for binding determinations 
[ 1251] hGH was incubated with liver membranes 
in 200 or 250 ~1 of 50 mM phosphate buffer pH 7.4, 
containing 0.1% bovine serum albumin. Incubations, 
in duplicate or triplicate, were carried out at room 
temperature for 120 min. Bound and free hormone 
was separated by centrifugation as follows: an aliquot 
(160 ~1) of each incubation mixture was added to 
800 ~1 of cold phosphate buffer in conical plastic 
tubes. These were centrifuged for 10 min at 4°C; the 
supernatants were aspirated and the pellets were 
washed once. Tips of tubes were cut off and counted 
in a Packard model 548. Parallel incubations were 
performed in the presence of excess unlabeled hGH 
(0.5 X low6 M). Specific binding was the difference 
between the total radioactive uptake and the amount 
that was not displaced by the excess of native hormone. 
3. Results and discussion 
The specificity of the binding of [ 1251] hGH to liver 
membranes from adult female and male rats is 
presented in fig.1. As shown in an earlier study [2] , 
hGH, oPRL and to a lesser extent bGH inhibit the bind- 
ing of [ 1251] bGH to liver membranes of female rats; the 
trations required for 50% inhibition are 2 X lo-’ M 
for hGH, 3 X 1 O-’ M for oPRL and 2.5 X 1 O-’ M for 
bGH (tig.lA). It is of interest that, differing with 
earlier studies [2,4], the apparent affinity of oPRL 
for the hGH binding sites is slightly but consistently 
lower than the one of hGH; maximal inhibition 
achieved by oPRL is always inferior to the one obtain- 
ed with hGH (fig.lA). This difference which does not 
occur when [1251] oPRL is used as a ligand (fig.2) 
suggests that, besides binding to the ‘lactogenic’ sites, 
hGH interacts with additional, ‘growth hormone’ 
binding sites. 
In males, which bind much less hGH than females, 
bGH and hGH are almost equivalent competitors, 
whereas oPRL competes for binding only at very high 
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F&l. Effects of native hGH (*), oPRL (4) and bGH (0) on the 
binding of [r2sI]hGH to liver membranes from female (A) and 
from male (B) adult rats. Liver membranes of female (0.80 mg 
protein/ml) and male (1.39 mg protein/ml) rats were incubated 
with [“‘I]hGH (0.88 X 10-i’ M and 1.58 X lO_” M 
respectively) and increasing concentration of native hormone. 
Binding is expressed as percent of the total radioactivity added 
per incubation. 
Fig.2. Specificity of [ ‘*51]~PRL binding to adult female rat 
liver membranes. Membranes (0.99 mg protein/ml) were 
incubated with [ ‘Z51]~PRL (1.45 X 10-r” M) and increasing 
concentrations of oPRL (4) and hGH ( l ). Binding is expressed 
as percent of the total radioactivity per incubation. 
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Fig.3. Specificity of [‘ZS1]hGH binding to adult female rat 
liver membranes in presence of an excess oPRL. Membranes 
(1.48 mg protein/ml) were preincubated for 30 min with 
oPRL (1 X low6 M); at this concentration oPRL gave 
maximal displacement that could be achieved (see fig.lA). 
[ ‘351]hGH (1.2 X lO_“’ M) was then added with increasing 
concentrations of hGH ( l ) and bGH (0). Incubation was 
continued for 90 min. Binding is expressed as percent of total 
radioactivity added per incubation. 
concentrations (fig. 1 B). These data indicate that, 
unlike in females, virtually all the binding sites in 
males have ‘growth hormone’ specificity. The same 
conclusions were suggested by our study of the inter- 
action of hGH with isolated rat liver cells [ Ill. 
More convincing evidence for sites with growth 
hormone specificity in female rats are obtained by 
saturating the lactogenic hormone specific sites 
with excess native oPRL (fig.3). Under these 
conditions, the residual binding of [r251]:rGH to liver 
membranes is, as in males, equally inhibited by hGH 
and bGH. It is also of interest that this residual 
binding is higher (1.5 times) than the [‘*‘I] hGH 
binding in males; a comparable difference is found in 
the membranes of the same animals when [ 1251] bGH 
is used as the tracer (fig.5). 
Variations of ‘lactogenic’ and ‘somatotropic’ sites 
with age and sex are shown in figs.4 and 5. In view of 
the identification of two types of binding sites in 
female rats, it was important to determine whether 
the increase in hGH binding capacity reported earlier 
reflected an increase only in lactogenic sites or in both 
‘lactogenic’ and ‘somatotropic’ binding sites. This was 
investigated by the use of [r251]hCH and [‘*‘I]bGH 
Fig.4. Specific binding of [“‘I] hGH to liver membranes of 
male ($) and female ((1) rats as a function of age. Rat liver 
membranes were incubated with [ “‘I]hGH (1.6 X lo-“’ M). 
Each bar represents specific binding expressed in moles of 
hormone bound per mg of membrane protein, and is the 
mean + SEM (vertical line) of at least 2 determinations. The 
number of animals used for each liver membrane preparation 
varied between 3 and 6. 
as tracers; the latter was assumed to bind only to 
‘growth hormone’ sites. These studies, in membranes 
of female rats, confirm that the hGH binding capacity 
increases by 4- to 6-fold after puberty and, in addition, 
they show a 2-fold increase in the bCH binding capacity. 
Thus the enhanced hGH binding capacity observed in 
postpubertal female rats reflects an increase in the 
number of both the ‘lactogenic’ and the ‘growth 
Fig.5. Specific binding of [ ‘zsI] bGH to liver membranes of 
male (1) and female (n) rats as a function of age. Rat liver 
membranes were incubated with [ “‘I]bGH (1.6 X 10-i” M). 
For expression of the results see legend to fig.4. 
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hormone’ binding sites. No increase with age in the 
number of ‘growth hormone’ binding sites is observed 
in males, the liver membranes of which bind the same 
amount of [12’1] bGH before and after puberty (fig.5). 
In both males and females, the number of growth 
hormone binding sites decreases after 3 months of age. 
The correlation between the binding to one or the 
other site and a specific biological activity of hGH in 
this system has to be investigated. The physiological 
significance of the modulation in the number of hGH 
binding sites remains to be established. 
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